Vereczkei, A.; Barta, C.; Magi, A.; Farkas, J.; Eisinger, A.; Király, O.; Belik, A.; Griffiths, M.D.; Szekely, A.; Sasvári-Székely, M.;
et al. FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors. J. Pers. Med. 2022, 12, 690.
https://doi.org/10.3390/jpm12050690
AMA Style
Vereczkei A, Barta C, Magi A, Farkas J, Eisinger A, Király O, Belik A, Griffiths MD, Szekely A, Sasvári-Székely M,
et al. FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors. Journal of Personalized Medicine. 2022; 12(5):690.
https://doi.org/10.3390/jpm12050690
Chicago/Turabian Style
Vereczkei, Andrea, Csaba Barta, Anna Magi, Judit Farkas, Andrea Eisinger, Orsolya Király, Andrea Belik, Mark D. Griffiths, Anna Szekely, Mária Sasvári-Székely,
and et al. 2022. "FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors" Journal of Personalized Medicine 12, no. 5: 690.
https://doi.org/10.3390/jpm12050690
APA Style
Vereczkei, A., Barta, C., Magi, A., Farkas, J., Eisinger, A., Király, O., Belik, A., Griffiths, M. D., Szekely, A., Sasvári-Székely, M., Urbán, R., Potenza, M. N., Badgaiyan, R. D., Blum, K., Demetrovics, Z., & Kotyuk, E.
(2022). FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors. Journal of Personalized Medicine, 12(5), 690.
https://doi.org/10.3390/jpm12050690